One of the NCBiotech portfolio companies there is Elysia Bio, founded in 2021 by Raleigh native and CEO Eli Hornstein, Ph.D.
"There's no box on our forms that says 'Are you using AI?' but it is an expectation," Alicia Pittman, BCG's global people ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
2don MSN
Parallel microdevice with AI-powered single-cell analysis enables rapid, high-throughput delivery
Many applications—from drug discovery and diagnostics to cell engineering and gene modulation—require delivering biomolecules ...
4don MSN
Bridge recombinases, optimized for human cells, enable massive programmable DNA rearrangements
For decades, gene-editing science has been limited to making small, precise edits to human DNA, akin to correcting typos in ...
The global mice model market is set to witness a growth rate of ~9% in the next 5 years. Increasing demand for personalized ...
The investment from Brown parents Giammaria and Sabrina Giuliani will support scholars seeking to unlock the potential of RNA ...
Earth’s most diverse biological entities are the viruses that infect bacteria, called bacteriophages (phages). They are rich ...
The new prime editors are about as efficient as their predecessors but make up to 60-fold fewer ‘indel’ mistakes.
This year, the GATE Life Sciences 2026 exam will be organised by IIT Guwahati. The official GATE Life Sciences syllabus PDF ...
Pharmaceutical Technology on MSN
Biogen’s high-dose Spinraza turned down by FDA due to CMC troubles
Biogen's Spinraza is not the first drug to face a CMC-related rejection recently, as SMA competitor drug, apitegromab, also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results